Aegerion Pharmaceuticals, Inc. to Webcast Investor Event: Challenges and Opportunities in HoFH

CAMBRIDGE, Mass., June 4, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will host an investor event focused on challenges and opportunities in the treatment of homozygous familial hypercholesterolemia (HoFH). The presentation will include a panel of physicians in the lipidology, cardiology and hepatology fields, as well as an HoFH patient. The event will be held on Tuesday, June 5, 2012, with the webcast scheduled to begin at 5:15 p.m. E.T.

Back to news